Savara
Likely to Engage tag.Highly Engaged Employees

Manufacturing · Pennsylvania, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

1717 Langhorne Newtown Rd Ste 302, Langh...

Phone Number

(512) 614-1848

Revenue

$7.8 Million

Stock Symbol

SVRA

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Savara

Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.Explore more
Savara's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: SVRAShow more

Savara Org Chart

PhoneEmail
Robert Lutz, Chief Operating Officer & Chief Financial Officer at Savara
United States flag for contact location.

Chief Operating Officer & Chief Financial Off...

PhoneEmail
SG
United States flag for contact location.

Senior Vice President, Chief of Staff

Flame icon indicating likelihood to engage via phone.PhoneEmail
Yasmine Wasfi, Chief Medical Officer at Savara
United States flag for contact location.

Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
SA
United States flag for contact location.

Global Executive VP, Technical Operations

PhoneEmail
CL
United States flag for contact location.

Executive VP, Affairs Head of Global Regulato...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Savara

Compare insights from companies similar to Savara, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Savara

$7.8M
51-200
Public
$227.5M
2007
Robert Lutz, Chief Operating Officer & Chief Financial Officer at Savara
Robert LutzChief Operating Officer & Chief Financial Officer
$95.4M
51-200
Public
$108.5M
1988
KK
Kris KandarpaExecutive Vice President & Chief Medical Officer, Research Development
$22.8M
51-200
Private
<$5M
1997
$5.4M
51-200
Private
-
2007
HM
Haji MakkiFinancial Controller
<$5M
11-50
Private
-
-
JH
Josh HermannProduction Foreman
<$5M
11-50
Private
-
2008
AS
Anna StashowerCEO and Publisher
<$5M
11-50
Private
<$5M
2000
Illustration of an envelope

Savara Tech Stack

A closer look at the technologies used by Savara

Top Manufacturing Companies

Frequently Asked Questions Regarding Savara

What is Savara's stock symbol?
Savara's stock symbol is SVRA
What is Savara's official website?
Savara's official website is www.savarapharma.com
What is Savara's Revenue?
Savara's revenue is $7.8 Million
What is Savara's SIC code?
Savara's SIC: 28,283
What is Savara's NAICS code?
Savara's NAICS: 32,325
How many employees does Savara have?
Savara has 51-200 employees
What industry does Savara belong to?
Savara is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Savara competition?
Savara top competitors include: Oakwood Labs, Delcath Systems, Globyz Pharma, Encap
What companies has Savara acquired?
Savara has acquired the companies: Aires Pharmaceuticals, SynthRx, SD Pharmaceuticals
What technology does Savara use?
Some of the popular technologies that Savara uses are: WordPress.org, PHP, Cloudflare Website Optimization, DoubleClick
Who is the CFO of Savara?
Savara's CFO is Robert Lutz
How do I contact Savara?
Savara contact info: Phone number: (512) 614-1848 Website: www.savarapharma.com
What does Savara do?

Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow® Neb... ulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.Read More

What are Savara social media links?
Savara Linkedin page Savara Twitter page
Who invested in Savara?
Savara has 13 investors including Keiretsu Forum Mid-Atlantic, Undisclosed, Undisclosed and Undisclosed.
Is Savara a public company?
Yes, Savara is a public company and is traded under the symbol SVRA
See more information about Savara

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.